Statins Reverse Doxorubicin Resistance in Mesothelioma Cells
NEW YORK JUL 12, 2006 (Reuters Health) – Statins reverse doxorubicin resistance in human malignant mesothelioma cells in culture, a finding that may lead to new clinical strategies to improve doxorubicin efficacy in this hard to treat cancer.
Read the rest of this entry »
Posted in The Medical News | 
No Comments » | July 12th, 2006
